⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GERN News
Geron Corp
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
prnewswire.com
NAGE
OCGN
NTLA
GERN
Form 8-K
sec.gov
GERN
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
globenewswire.com
GERN
Geron Plans to Present at Upcoming Investor Conferences
globenewswire.com
GERN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
Stem Cell Therapy Market to Reach USD 45.2B by 2036 (8.4% CAGR) | U.S., Germany & Japan Lead Growth | Mesenchymal Stem Cells Hold 45% Share -- Future Market Insights
prnewswire.com
MESO
GERN
BCDA
NVS
BMY
Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
globenewswire.com
GERN
Chemotherapy-Induced Anemia Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast to 2031
globenewswire.com
GERN
AMGN
CSL
Next Generation Drug Conjugates Market Trends and Global Forecasts, 2025-2035 - Lutathera, Pluvicto, Givlaari, Oxlumo, Leqvio, and Amvuttra Represent Milestones in Advanced Treatment Solutions - ResearchAndMarkets.com
businesswire.com
NVS
ALNY
ARWR
GERN
IONS
Mats Inc Reintroduces Itself as a Matter Surfaces Brand to Enhance the Digital Experience with a New Website
globenewswire.com
GERN